86.63
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$86.06
Aprire:
$85.86
Volume 24 ore:
4.58M
Relative Volume:
0.56
Capitalizzazione di mercato:
$111.22B
Reddito:
$35.48B
Utile/perdita netta:
$4.64B
Rapporto P/E:
24.18
EPS:
3.582
Flusso di cassa netto:
$5.41B
1 W Prestazione:
-1.19%
1M Prestazione:
-11.69%
6M Prestazione:
-9.27%
1 anno Prestazione:
-2.51%
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
|
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Ripresa | Barclays | Overweight |
| 2026-02-09 | Aggiornamento | Needham | Hold → Buy |
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2026-01-30 | Ripresa | Wells Fargo | Overweight |
| 2026-01-06 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Perpetual Ltd Sells 97,299 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic plc (MDT) stock price, news, quote and history - Yahoo Finance UK
SteelPeak Wealth LLC Invests $3.70 Million in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Acquired by Global Trust Asset Management LLC - MarketBeat
Medtronic Outperforms MacroGenics in Financial Comparison - National Today
Medtronic plc (MDT.VI) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot - The Chronicle-Journal
Genesis Financial Group LLC Acquires Shares of 48,805 Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Stake Lifted by Aberdeen Group plc - MarketBeat
Medtronic PLC $MDT Stake Increased by HF Advisory Group LLC - MarketBeat
Medtronic plc Stock: Navigating Transformation and Growth in MedTech Amid Analyst Shifts - AD HOC NEWS
Global Biomedical Sensor Market Poised for Strong Growth as Rising Demand for Real-Time Health Monitoring and Advancements in Wearable Technologies Accelerate Adoption: Verified Market Research® - GlobeNewswire Inc.
The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan - The Chronicle-Journal
Tempus AI, Medtronic Report Positive Clinical Trial Results for Medical Alert System - MarketScreener
MDT Stock May Gain From FDA's Nod for Stealth AXiS Surgical System - TradingView
Piper Sandler Adjusts Medtronic Price Target to $91 From $105, Maintains Neutral Rating - MarketScreener
Capital Advisors Inc. OK Grows Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Stake Lessened by Allspring Global Investments Holdings LLC - MarketBeat
Did FDA’s Stealth AXiS Expansion Just Rewire Medtronic’s (MDT) AI Surgery Investment Narrative? - Yahoo Finance
Medtronic PLC stock rises Tuesday, still underperforms market - MarketWatch
MiniMed gains amid bullish views from analysts (MMED:NASDAQ) - seekingalpha.com
Medtronic to study renal denervation combined with PCI - MedTech Dive
Medtronic wins CE mark for OmniaSecure defibrillation lead - MedTech Dive
Barclays Adjusts Price Target on Medtronic to $120 From $118, Maintains Overweight Rating - MarketScreener
Medtronic Returns to Fast Company's Most Innovative Companies List for Second Year in a Row - MarketScreener
Medtronic Returns to Fast Company's Most Innovative Companies List For Second Year in a Row - Investing News Network
Medtronic (MDT) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Medtronic PLC stock underperforms Monday when compared to competitors - MarketWatch
FDA clears Medtronic’s Stealth Axis system for cranial and ENT procedures - Medical Device Network
Medtronic wins FDA clearance for robot in cranial, ENT surgeries - MedTech Dive
Wound Film Dressing Market Set to Boom Rapidly by 2033 | Medtronic • Coloplast • Hollister Incorporated - openpr.com
Exchange Traded Concepts LLC Buys 28,569 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic plc (NYSE:MDT) Q4 2025 Earnings Call Transcript - MSN
Jim Cramer on Medtronic (MDT): "I think that everything they’ve been doing lately is right" - MSN
MDT SEC FilingsMedtronic 10-K, 10-Q, 8-K Forms - Stock Titan
Jim Cramer on Medtronic (MDT): “I Think That Everything They’ve Been Doing Lately Is Right” - Insider Monkey
ACC.26: Medtronic announces support for EMBRACE investigator-initiated study focused on high cardiovascular risk patients - marketscreener.com
Nepsis Inc. Buys Shares of 88,696 Medtronic PLC $MDT - MarketBeat
Medtronic Plc Trade Ideas — BSESOF:2M6 - TradingView
Medtronic (NYSE:MDT) Raised to "Buy" at Wall Street Zen - MarketBeat
Quick ratio of Medtronic Plc – BSESOF:2M6 - TradingView
Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries - Reuters
ETFs Investing in Medtronic Plc Stocks - TradingView
Medtronic: Time For A Growth Spurt (NYSE:MDT) - Seeking Alpha
Vanguard discloses zero holding in Medtronic (NYSE: MDT) — Amendment No.10 - Stock Titan
Medtronic Stealth AXiS cleared for cranial procedures (MDT) - Seeking Alpha
Medtronic and Merit Launch ViaVerte for Back Pain - Precedence Research
Medtronic Says Stealth AXiS Surgical System Receives FDA Clearance for Cranial, ENT Procedures - MarketScreener
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures - Medtronic
Neonatal & Fetal Monitors Market Grows with Philips, GE Healthcare, Medtronic Leading - National Today
Synergy Asset Management LLC Has $3.37 Million Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):